VANCOUVER, British Columbia, July 27, 2021 (GLOBE NEWSWIRE) – ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Different” or the “Company”) plant-based nutrition for babies, toddlers and children company, continues its mission to change the face of early childhood nutrition with sustainable, clean, wholesome products as it enters the baby nutrition area with a line of complementary nutrition for baby cereals.

The cereals are designed to help those families struggling with dairy intolerance, those embarking on a plant-based lifestyle, and those unwilling to accept the overly processed formulas / nutritional products currently available. The addition of this new line of products will provide parents with a wider variety of healthy diet alternatives.

The company is breaking new ground for the Else brand with the current introduction of nutritional supplements for babies from 6 months of age. This follows the rapid launch of its original complete plant-powered infant formula and infant complete plant-powered diet shake, which launched in June 2021. This new line complements infant and toddler foods and is also derived from organic almonds, buckwheat, and tapioca, all clean, minimally processed whole ingredients that retain their full nutritional benefits.

“This is an important milestone for the company as we continue our goal of providing a full line of pure plant-based nutrition for infants, toddlers and toddlers,” said Hamutal Yitzhak, CEO and co-founder of Else Nutrition. “These clean, nutritious baby cereals expand our offerings significantly and create a bridgehead in the large and growing infant formula market,” she added.

Cereal products for infants and young children account for nearly 40% of the fast-growing U.S. baby food market, which was valued at $ 12.9 billion in 2018 and is projected to reach $ 17.2 billion by 2026, with an annual growth rate of 3 .7% from 2019 to 2026.1

The new product line will initially be available in the original, banana and mango flavors, with further flavors to follow.


For more information visit: or @elsenutrition on Facebook and Instagram.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutritional products for infants, toddlers, children and adults. Its revolutionary, soy-free, plant-based formula is an alternative to pure milk-based ingredients. Else Nutrition (formerly INDI) was awarded the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company Else Nutrition Holdings Inc. is a publicly traded company, listed as the TSX Venture Exchange under the symbol BABY and on the US OTC Markets QX Board under the symbol BABYF and on the Frankfurt Stock Exchange under the symbol 0YL. written down . Else executives include executives from leading baby food companies. Many of Else’s advisory board members have held previous leadership positions at companies such as Mead Johnson, Abbott Nutrition, Plum Organics, and leading child nutrition companies, and some of them are currently in various roles at leading medical centers and academic institutions such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

Media contact
Erin Jundef
Brilliant PR
E: [email protected]

For more information contact:
Ms. Hamutal Yitzhak, CEO, Co-Founder and Director
ELSE Nutrition Holdings Inc.
E: [email protected]
Phone: +972 (0) 3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
E: [email protected]
P: 604-603-7787

US Investor Relations contact
Lytham Partners, LLC
Mr. Ben Shamsian
New York | Phoenix
E: [email protected]
P: 646-829-9701

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulator (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Beware of forward-looking statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are usually identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements regarding the anticipated dates for filing the company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions that are based on management’s perception of current conditions and expected future developments, as well as on other factors that management considers appropriate under the given circumstances. There can be no assurance that the foregoing will prove to be correct. Forward-looking statements in this press release assume, among other things, that there will be no interruptions or failures in the supply chain due to COVID 19 and that the manufacturing, brokerage and delivery logistics agreement with the company will not end. Actual results could differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which only reflect management’s expectations as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements as a result of new information, future events or for any other reason, except as required by law.

A photo accompanying this announcement is available at